The neutropenia induced by the thalidomide analogue CC-4047 in patients with multiple myeloma is associated with an increased percentage of neutrophils bearing CD64D. McCarthy, K A Brown, Marion G. Macey et al.|International Immunopharmacology|2006Cited by 13
Changes in neutrophil phenotype following the administration of CC-4047 (Actimid) to patients with multiple myeloma.Matthew Streetly, Stephen Schey, M. G. Macey et al.|Research Portal (King's College London)|2003Cited by 1